Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma
Ruxolitinib for Adult T-Cell Leukemia
|3||Active, not recruiting||
EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
† Study has passed its completion date and status has not been verified in more than two years.